(PharmaNewsWire.Com, September 13, 2019 ) Market Overview: Melanoma is one of the serious types of skin cancer that develops from pigment-containing cells called melanocytes. Skin cancer is of three types: basal cell carcinoma, squamous cell carcinoma, and melanoma. UV radiations from sunlight are the primary cause of melanoma. In certain cases, genes can also be cause for melanoma. According to the World Health Organization (WHO), about 132,000 melanoma skin cancers occur each year globally.
Market Dynamics: The market is driven by the rising prevalence of melanoma, improvement in healthcare facilities, government initiatives and innovation of medicines with better efficiency. Lack of awareness of the disease and high cost associated with the therapy are going to hamper the market growth over the period of forecast.
Market Segmentation: By Stage Stage 0 Stage I Stage II Stage III Stage IV
By Therapy Surgery Immunotherapy Targeted Therapy Chemotherapy Radiation Therapy
Geographical Analysis: By Geography, the market is segmented into: North America Europe South America Asia Pacific The Middle East and Africa
Competitive Analysis: Key Players: Bristol-Myers Squibb Co. * Merck and Co., Inc. F. Hoffmann-La Roche, Ltd. AB Science S.A. Amgen, Inc. Celgene Corp. Others
About Us: DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information: Sai Kiran Sales Manager at Data M Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
